The October 2010 FDA Patient Safety News is now available...

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: The October 2010 FDA Patient Safety News is now available...

In this special edition of FDA Patient Safety News, we are repeating some of the most important safety issues that continue to pose public health problems.  You can find more information about the show, read the complete stories and watch or download the program on our web site (http://www.fda.gov/psn): 

 

Importance of Influenza Vaccination for Health Care Personnel

Ensuring that healthcare staff are vaccinated can reduce staff influenza rates as well as nosocomial infection rates…

 

Preventing Cross-Contamination in Endoscope Processing

Continuing reports of processing errors prompt joint communication from FDA, CDC and VA…

 

Never Use Parenteral Syringes for Oral Medications

Once a parenteral syringe is filled with a liquid intended for oral use, it can be accidentally connected to an intravenous line, with potentially dangerous consequences…

 

Burns from Medicated Patches during MRI Exams

Because the metallic component in a number of OTC and prescription transdermal patches can conduct heat, patients should remove the patch before the MRI...

 

Drug Name Confusion: Ephedrine and Epinephrine

ISMP’s recommendations to help prevent mix-ups between ephedrine and epinephrine…

 

Cautions about Sexual Enhancement Products

“All natural” supplements may contain ingredients that could pose a serious health risk…

 

For more FDA Patient Safety News, visit http://www.fda.gov/psn .  Please send any comments, questions or suggestions about the program to PSNews@xxxxxxx

 

You are receiving this message because you subscribed to the FDA Patient Safety News mailing list. If you would like to modify your subscription or no longer wish to receive these messages, please go to http://www.accessdata.fda.gov/psn/mailinglist.cfm

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420